Acta Neuropathologica

, Volume 75, Issue 2, pp 185–198 | Cite as

Brain pathology induced by infection with the human immunodeficiency virus (HIV)

A histological, immunocytochemical, and electron microscopical study of 100 autopsy cases
  • H. Budka
  • G. Costanzi
  • S. Cristina
  • A. Lechi
  • C. Parravicini
  • R. Trabattoni
  • L. Vago
Regular Papers


Neuropathological examination of brain tissue of 100 patients with infection by the human immunodeficiency virus (HIV), including 98 with clinically manifest acquired immune deficiency syndrome (AIDS), revealed distinct multifocal-disseminated and diffuse brain tissue lesions, which can be regarded as HIV-induced brain lessions: multifocal giant cell encephalitis (MGCE; 4) and progressive diffuse leukoencephalopathy (PDL; 25). These lesions were found in 38 brains, and in 17 in absence of infectious, necrotizing or inflammatory changes of other types. In 13 brains, a combination of MGCE with PDL was seen, suggesting a spectrum of HIV-induced brain lesions. MGCE is characterized by perivascular accumulations predominantly of rod cells, monohistiocytes and macrophages, all of which are strongly labeled with a monoclonal antibody to macrophages. Most conspicuous are multinucleated giant cells which are also labeled by anti-macrophage antibody, and which can be regarded as evidence of the local presence of HIV, as confirmed by electron microscopical detection of HIV particles in four MGCE brains, and by immunocytochemical detection of HIV proteins in two MGCE brains. PDL is characterized by a triad: diffuse myelin loss, astroglial proliferation, and infiltration by mono- and multinucleated macrophages. HIV-induced lesions can be morphologically differentiated from histopathological brain lesions known in immunosuppression, including what is called here nodular encephalitis [“subacute encephalitis” of the literature, in most cases attributable to cytomegalovirus (CMV) or toxoplasmosis], by their characteristic histopathology including the hallmark presence of multinucleated giant cells, by direct immunocytochemical and electron microscopical demonstration of HIV in the lesions, and by the absence of opportunistic agents (bacteria, fungi, Toxoplasma, CMV, HSV or papovaviruses). Diffuse poliodystrophy (diffuse proliferation of astroglia with swollen nuclei, occasionally minor neuronal loss and rod cell proliferation) was found in the cerebral cortex and other gray matter in half of all brains, including cases with gyral atrophy, and may be another correlate of HIV damage to the brain. Morphological delineation of HIV-induced brain lesions is a necessary prerequisite for a meaningful clinical definition of HIV-induced cerebral disease.

Key words

Human Immunodeficiency Virus (HIV) Retrovirus Acquired Immunodeficiency Syndrome (AIDS) Brain lesion Immunocytochemistry 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Anand R, Reed C, Forlenza S, Siegal F, Cheung T, Moore J (1987) Non-cytocidal natural variants of human immunodeficiency virus isolated from AIDS patients with neurological disorders. Lancet II:234–238Google Scholar
  2. 2.
    Anders KH, Guerra WF, Tomiyasu U, Verity MA, Vinters HV (1986) The neuropathology of AIDS. UCLA experience and review. Am J Pathol 124:537–558Google Scholar
  3. 3.
    Barnes DM (1987) Brain damage by AIDS under active study. Science 235:1574–1577Google Scholar
  4. 4.
    Budka H (1986) Multinucleated giant cells in brain: a hallmark of the acquired immune deficiency syndrome (AIDS). Acta Neuropathol (Berl) 69:253–258Google Scholar
  5. 5.
    Budka H (1987) Das morphologische Korrelat der HIV-Infektion des Gehirns. In: Fischer P-A, Schlote W (eds) AIDS und Nervensystem. Springer, Berlin Heidelberg New York Tokyo, pp 117–132Google Scholar
  6. 6.
    Budka H, Lassmann H (1988) Human immunodeficiency virus (HIV) in glia? J Infect Dis (in press)Google Scholar
  7. 7.
    Budka H, Popow-Kraupp Th (1981) Rabies and herpes simplex virus encephalitis. An immunohistological study on site and distribution of viral antigens. Virchows Arch [A] 390:353–364Google Scholar
  8. 8.
    Budka H, Shah KV (1983) Papovavirus antigens in paraffin sections of PML brains. Prog Clin Biol Res 105:299–309Google Scholar
  9. 9.
    Budka H, Jellinger K, Wolf A, Zazgornik J, Stummvoll HK, Schmidt P, Pinggera WF, Kopsa H (1976) Neuropathologische Befunde nach Nierentransplantation. Wien Klin Wochenschr 88:175–179Google Scholar
  10. 10.
    Budka H, Costanzi G, Cristina S, Lechi A, Trabattoni G (1987) Morphological correlates of cerebral HIV infection. In: Kubicki S, Henkes H, Bienzle U (eds) HIV and nervous system. Fischer, Stutgart New York (in press)Google Scholar
  11. 11.
    Centers for Disease Control (1985) Revision of the case definition of acquired immunodeficiency syndrome for national reporting — United States. Ann Intern Med 103:402–403Google Scholar
  12. 12.
    Chiodi F, Asjö B, Fenyö E-M, Norkrans G, Hagberg L, Albert J (1986) Isolation of human immunodeficiency virus from cerebrospinal fluid of antibody-positive virus carriers without neurological symptoms. Lancet II:1276–1277Google Scholar
  13. 13.
    Dickson DW (1986) Multinucleated giant cells in acquired immunodeficiency syndrome encephalopathy. Origin from endogenous microglia? Arch Pathol Lab Med 110:967–968Google Scholar
  14. 14.
    Dorfman LJ (1973) Cytomegalovirus encephalitis in adults. Neurology 23:136–144Google Scholar
  15. 15.
    Epstein LG, Sharer LR, Joshi VV, Fojas MM, Koenigsberger MR, Oleske JM (1985) Progressive encephalopathy in children with acquired immune deficiency syndrome. Ann Neurol 17:488–496Google Scholar
  16. 16.
    Epstein LG, Sharer LR, Cho E-S, Myenhofer M, Navia BA, Price RW (1985) HTLV-III/LAV-like retrovirus particles in the brains of patients with AIDS encephalopathy. AIDS Res 1:447–454Google Scholar
  17. 17.
    Gabuzda DH, Ho DD, de la Monte SM, Hirsch MS, Rota TR, Sobel RA (1986) Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Ann Neurol 20:289–295Google Scholar
  18. 18.
    Gartner S, Markovits P, Markovitz DM, Betts RF, Popovic M (1986) Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS. J Am Med Assoc 256:2365–2371Google Scholar
  19. 19.
    Gelderblom HR, Hausmann EHS, Özel M, Pauli G, Koch MA (1987) Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology 156:171–176Google Scholar
  20. 20.
    Gonda MA, Wong-Staal F, Gallo RC, Clements JE, Narayan O, Gilden RV (1985) Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus. Science 227:173–177Google Scholar
  21. 21.
    Gray F, Gherardi R, Baudrimont M, Gaulard P, Meyrignac C, Vedrenne C, Poirier J (1987) Leucoencephalopathy with multinucleated giant cells containing human immune deficiency virus-like particles and multiple opportunistic cerebral infections in one patient with AIDS. Acta Neuropathol (Berl) 73:99–104Google Scholar
  22. 22.
    Gyorkey F, Melnick JL, Gyorkey P (1987) Human immunodeficiency virus in brain biopsies of patients with AIDS and progressive encephalopathy. J Infect Dis 155:870–876Google Scholar
  23. 23.
    Ho DD, Rota TR, Schooley RT, Kaplan JC, Allan JD, Groopman JE, Resnick L, Felsenstein D, Andrews CA, Hirsch MS (1985) Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 313:1493–1497Google Scholar
  24. 24.
    Johnson RT (1982) Viral infections of the nervous system. Raven Press, New York, pp 239–241Google Scholar
  25. 25.
    Kato T, Hirano A, Llena JF, Dembitzer HM (1987) Neuropathology of acquired immune deficiency syndrome (AIDS) in 53 autopsy cases with particular emphasis on microglial nodules and multinucleated giant cells. Acta Neuropathol (Berl) 73:287–294Google Scholar
  26. 26.
    Kleihues P, Lang W, Burger PC, Budka H, Vogt M, Maurer R, Lüthy R, Siegenthaler W (1985) Progressive diffuse leukoencephalopathy in patients with acquired immune deficiency syndrome (AIDS). Acta Neuropathol (Berl) 68:333–339Google Scholar
  27. 27.
    Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, Yungbluth M, Janotta F, Aksamit A, Martin MA, Fauci AS (1986) Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233:1089–1093Google Scholar
  28. 28.
    Koyanagi Y, Miles S, Mitsuyasu RT, Merrill JE, Vinters HV, Chen ISY (1987) Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236:819–822Google Scholar
  29. 29.
    Levy JA, Shimabukuro J, Hollander H, Mills J, Kaminsky L (1985) Isolation of AIDS-associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms. Lancet II:586–588Google Scholar
  30. 30.
    Mannoji H, Yeger H, Becker LE (1986) A specific histochemical marker (lectin Ricinus communis agglutinin-1) for normal human microglia, and application to routine histopathology. Acta Neuropathol (Berl) 71:341–343Google Scholar
  31. 31.
    Meyenhofer MF, Epstein LG, Cho E-S, Sharer LR (1987) Ultrastructural morphology and intracellular production of human immunodeficiency virus (HIV) in brain. J Neuropathol Exp Neurol 46:474–484Google Scholar
  32. 32.
    Monte de la SM, Ho DD, Schooley RT, Hirsch MS, Richardson EP Jr (1987) Subacute encephalomyelitis of AIDS and its relation to HTLV-III infection. Neurology 37:562–569Google Scholar
  33. 33.
    Navia BA, Jordan BD, Price RW (1986) The AIDS dementia complex. I. Clinical features. Ann Neurol 19:517–524Google Scholar
  34. 34.
    Navia BA, Cho E-S, Petito CK, Price RW (1986) The AIDS dementia complex. II. Neuropathology. Ann Neurol 19: 525–535Google Scholar
  35. 35.
    Oehmichen M (1982) Functional properties of microglia. In: Smith WT, Cavanagh JB (eds) Recent advances in neuropathology, vol 2. Churchill Livingstone, Edinburgh, pp 83–107Google Scholar
  36. 36.
    Petito CK, Navia BA, Cho E-S, Jordan BD, George DC, Price RW (1985) Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Engl J Med 312:874–879Google Scholar
  37. 37.
    Petito CK, Cho E-S, Lemann W, Navia BA, Price RW (1986) Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J Neuropathol Exp Neurol 45:635–646Google Scholar
  38. 38.
    Popovic M, Sarngadharan MG, Read E, Gallo RC (1984) Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497–500Google Scholar
  39. 39.
    Pumarola-Sune T, Navia BA, Cordon-Cardo C, Cho E-S, Price RW (1987) HIV antigen in the brains of patients with the AIDS dementia complex. Ann Neurol 21:490–496Google Scholar
  40. 40.
    Resnick L, di Marzo-Veronese F, Schüpbach J, Tourtelotte WW, Ho DD, Müller F, Shapshak P, Vogt M, Groopman JE, Markham PD, Gallo RC (1985) Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. N Engl J Med 313:1498–1504Google Scholar
  41. 41.
    Rosemberg S, Lopes MBS, Tsanaclis AM (1986) Neuropathology of acquired immunodeficiency syndrome (AIDS). Analysis of 22 Brazilian cases. J Neurol Sci 76:187–198Google Scholar
  42. 42.
    Schober R, Herman MM (1973) Neuropathology of cardiac transplantation. Survey of 31 cases. Lancet I:962–967Google Scholar
  43. 43.
    Seitelberger F (1975) General neuropathology of the degenerative diseases of the central nervous system. In: Vinken PJ, Bruyn GW (eds) Handb Clin Neurol 21:43–71Google Scholar
  44. 44.
    Sharer LR, Cho E-S, Epstein LG (1985) Multinucleated giant cells and HTLV-III in AIDS encephalopathy. Hum Pathol 16:760Google Scholar
  45. 45.
    Sharer LR, Epstein LG, Cho E-S, Joshi VV, Meyenhofer MF, Rankin LF, Petito CK (1986) Pathologic features of AIDS encephalopathy in children: evidence for LAV/HTLV-III infection of brain. Hum Pathol 17:271–284Google Scholar
  46. 46.
    Shaw GM, Harper ME, Hahn BH, Epstein LG, Gajdusek DC, Price RW, Navia BA, Petito CK, O'Hara CJ, Groopman JE, Cho E-S, Oleske JM, Wong-Staal F, Gallo RC (1985) HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science 227:177–182Google Scholar
  47. 47.
    Snider WD, Simpson DM, Nielsen S, Gold JWM, Metroka CE, Posner JB (1983) Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 14:403–418Google Scholar
  48. 48.
    Stoler MH, Eskin TA, Benn S, Angerer RC, Angerer LM (1986) Human T-cell lymphotropic virus type III infection of the central nervous system. A preliminary in situ analysis. J Am Med Assoc 256:2360–2364Google Scholar
  49. 49.
    Vazeux R, Brousse N, Jarry A, Henin D, Marche C, Vedrenne C, Mikol J, Wolff M, Michon C, Rozenbaum W, Bureau J-F, Montagnier L, Brahic M (1987) AIDS subacute encephalitis. Identification of HIV-infected cells. Am J Pathol 126:403–410Google Scholar
  50. 50.
    Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MBA (1986) Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 83:7089–7093Google Scholar
  51. 51.
    Wisniewski HM, Bloom BR (1975) Primary demyelination as a nonspecific consequence of a cell-mediated immune response. J Exp Med 141:346–359Google Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • H. Budka
    • 1
  • G. Costanzi
    • 2
  • S. Cristina
    • 2
  • A. Lechi
    • 3
  • C. Parravicini
    • 2
  • R. Trabattoni
    • 3
  • L. Vago
    • 2
  1. 1.Neurologisches Institut der UniversitätViennaAustria
  2. 2.5th Chair of Pathological Anatomy and HistologyUniversity of Milan, Hospital “L. Sacco”MilanoItaly
  3. 3.Neurological ClinicUniversity of ParmaParmaItaly

Personalised recommendations